Atlas Trials

Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Clinical trial NCT04315792 · COMPLETED

Trial details

NCT number
NCT04315792
Sponsor
Jina Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar I Disorder
Start date
2020-08-03
Primary completion
2021-01-25
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.